Feasibility Study of CBCT for IGRT in Cancer Patients
Phase NA Recruiting
50 enrolled
MOMENTUM
Recruiting
8,000 enrolled
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Phase 2 Recruiting
24 enrolled
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Recruiting
750 enrolled
SELECT-CAR-NK
Phase 1/2 Recruiting
85 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
80 enrolled
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
Phase 1 Recruiting
150 enrolled
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Phase 1/2 Recruiting
796 enrolled
iCaRe2
Recruiting
999,999 enrolled
PTC-IMPACT
Recruiting
50 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
OvAR-Y
Recruiting
10 enrolled
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
15 enrolled
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2 Recruiting
51 enrolled
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
115 enrolled
Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 Recruiting
11 enrolled
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
Phase NA Recruiting
10 enrolled
INSPIRE
Recruiting
5,350 enrolled
DISRUPT
Phase NA Recruiting
644 enrolled
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
Phase NA Recruiting
1,000,000 enrolled
LEARN
Recruiting
300 enrolled
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
Phase 1 Recruiting
40 enrolled
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Phase 1/2 Recruiting
100 enrolled
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
Recruiting
3,200 enrolled
CER
Recruiting
15,000 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Recruiting
2,700 enrolled
ONCOPRO
Phase NA Recruiting
410 enrolled